Autoimmune pancreatitis with retroperitoneal fibrosis which responded to steroid therapy but was complicated with refractory renal dysfunction. |
||||
| A 58-year-old male had been diagnosed as having autoimmune pancreatitis (AIP) from the results of serological examinations and image findings. He was treated with prednisolone (PSL) for 3.5 months. Fifteen months later, follow-up CT revealed the main pancreatic duct (MPD) dilatation in the pancreas body to tail and right hydronephrosis caused by complicated...more | ||||
|
||||
Effect of early corticosteroid therapy on development of Henoch-Schönlein nephritis. |
||||
| BACKGROUND: Henoch-SchAtilde;para;nlein purpura (HSP) is a systemic, small vessel vasculitis, which is very common among pediatric population. Findings of previous reports addressing the preventive effect of corticosteroid treatment in HSP nephritis have been inconsistent. The aim of this study was to determine whether corticosteroid therapy was effective...more | ||||
|
||||
Effects of portal versus systemic venous drainage in pancreas and kidney-pancreas transplantation. |
||||
| We performed a retrospective analysis to compare pancreas transplantation with systemic-enteric drainage (SE) or portal-enteric drainage (PE). METHODS: We reviewed 38 consecutive pancreas transplants including 31 simultaneous kidney-pancreas (SKP) and 7 pancreas after kidney (PAK), using either systemic (n = 18) or portal (n = 20) venous drainage....more | ||||
|
||||
Effect of detoxification, removing stasis and nourishing yin method on corticosteroid-induced hyperlipidemia in patients with systemic lupus erythematosus. |
||||
| OBJECTIVE: To observe the effect of TCM therapy for detoxification, removing stasis, and nourishing yin on corticosteroid-induced hyperlipemia in patients with systemic lupus erythematosus (SLE), and to investigate its mechanism. METHODS: One hundred and seventy patients with SLE were randomly assigned to the integrative medicine group (IM group)...more | ||||
|
||||
High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myeloma. |
||||
| Immunoglobulin D (IgD) multiple myeloma (MM) is a rare plasma cell disorder constituting less than 2 of all MM cases. Survival of patients with IgD MM is generally shorter than that of patients with other types of monoclonal (M-) protein. We have retrospectively analyzed patients with IgD MM participating in clinical trials of the Czech Myeloma...more | ||||
|
||||
What side effects can this medication cause |
||||
|
||||
|
||||
